Older RSV Hospitalization Linked to Pneumonia - Report - MDSpire

Older RSV Hospitalization Linked to Pneumonia

  • By

  • Conexiant News Staff

  • March 11, 2026

  • 3 min

Share

Clinical Report: Older RSV Hospitalization Linked to Pneumonia

Overview

A large cohort study in Sweden indicates that children hospitalized for respiratory syncytial virus (RSV) at older ages have a significantly increased risk of subsequent bacterial pneumonia. The risk escalates with age at first RSV hospitalization, particularly for those hospitalized between 18 and 23 months.

Background

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children, resulting in millions of hospitalizations annually. Understanding the long-term consequences of RSV hospitalization, particularly the risk of bacterial pneumonia, is crucial for developing effective prevention strategies. This study highlights the need for targeted interventions to mitigate the risks associated with RSV in older infants and toddlers.

Data Highlights

{'table': {'rows': [{'age': '0-5 months', 'risk': '5 times higher'}, {'age': '18-23 months (first 2 months)', 'risk': '8 times higher'}, {'age': '18-23 months (after 2 months)', 'risk': '4 times higher'}]}}

Key Findings

  • Children hospitalized for RSV at older ages face a higher risk of bacterial pneumonia.
  • The risk is highest shortly after RSV hospitalization and increases with age at first hospitalization.
  • Children hospitalized between 18 and 23 months are more than eight times likely to be hospitalized for bacterial pneumonia shortly after RSV infection.
  • Age-related immune response differences may contribute to increased susceptibility to bacterial complications.
  • Preventing RSV infections in early childhood could reduce the risk of subsequent bacterial pneumonia.

Clinical Implications

Healthcare providers should be aware of the increased risk of bacterial pneumonia in children hospitalized for RSV, especially those older than 18 months. This knowledge can inform monitoring and preventive strategies, including vaccination and early intervention for at-risk populations.

Conclusion

The findings underscore the importance of preventing RSV infections in early childhood to mitigate the risk of bacterial pneumonia, suggesting a need for enhanced RSV prevention strategies.

References

  1. The Journal of Infectious Diseases, 2023 -- Hospitalization Rates and Outcomes for Respiratory Syncytial Virus and Human Metapneumovirus in Adults Aged 50 and Older in Colorado
  2. The Journal of Infectious Diseases, 2023 -- Clinical Characteristics and In-hospital Outcomes Associated With Respiratory Syncytial Virus vs Other Viral Acute Lower Respiratory Infections in Hospitalized Children Younger Than 2 Years
  3. Infection, 2024 -- Infection with Respiratory Syncytial Virus Among Patients with Hematological Disorders: A Retrospective Multicenter Analysis
  4. The Journal of Infectious Diseases, 2023 -- Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017–2019
  5. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices, 2023
  6. Nirsevimab for Prevention of RSV Hospitalizations in Infants - PubMed
  7. Increased risk of bacterial pneumonia before and after respiratory syncytial virus infection in young children - PubMed
  8. CDC Guidance on RSV Prevention
  9. Nirsevimab for Prevention of RSV Hospitalizations in Infants - PubMed
  10. Increased risk of bacterial pneumonia before and after respiratory syncytial virus infection in young children - PubMed

Original Source(s)

Related Content